Literature DB >> 21712406

FoxM1: a master regulator of tumor metastasis.

Pradip Raychaudhuri1, Hyun Jung Park.   

Abstract

The FoxM1 transcription factor gene is overexpressed in cancer. Its expression is stimulated by oncogenic signaling pathways and reactive oxygen species. It is also a target of regulation by the tumor suppressor genes. The transcriptional activity of FoxM1 depends upon activation by cyclin and cyclin-dependent kinases as well as Plk1. FoxM1 stimulates expression of several genes involved in the cell cycle progression. Moreover, it supports proliferation of tumor cells by stimulating expression of the antioxidant genes and reducing oxidative stress. A new study provides evidence that FoxM1, in the absence of its inhibitor, the tumor suppressor Arf, drives metastasis of hepatocellular carcinoma (HCC). It induces an epithelial-mesenchymal-like transition phenotype in HCC cells, increases cell migration, and induces premetastatic niche at the distal organ of metastasis. FoxM1 directly activates genes involved in multiple steps of metastasis. In this review, we discuss the evidence for a master regulatory role of FoxM1 in tumor metastasis. ©2011 AACR.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21712406      PMCID: PMC3129416          DOI: 10.1158/0008-5472.CAN-11-0640

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  30 in total

1.  A conserved phosphorylation site within the forkhead domain of FoxM1B is required for its activation by cyclin-CDK1.

Authors:  Yi-Ju Chen; Carmen Dominguez-Brauer; Zebin Wang; John M Asara; Robert H Costa; Angela L Tyner; Lester F Lau; Pradip Raychaudhuri
Journal:  J Biol Chem       Date:  2009-09-08       Impact factor: 5.157

Review 2.  Metastamir: the field of metastasis-regulatory microRNA is spreading.

Authors:  Douglas R Hurst; Mick D Edmonds; Danny R Welch
Journal:  Cancer Res       Date:  2009-09-22       Impact factor: 12.701

Review 3.  Intrahepatic dissemination of hepatocellular carcinoma after local ablation therapy.

Authors:  Toshiro Masuda; Toru Beppu; Takatoshi Ishiko; Kei Horino; Yoshifumi Baba; Takao Mizumoto; Hiromitsu Hayashi; Hirohisa Okabe; Hasita Horlad; Koichi Doi; Kazutoshi Okabe; Hiroshi Takamori; Masahiko Hirota; Ken-ichi Iyama; Hideo Baba
Journal:  J Hepatobiliary Pancreat Surg       Date:  2008-11-07

4.  FoxM1, a critical regulator of oxidative stress during oncogenesis.

Authors:  Hyun Jung Park; Janai R Carr; Zebin Wang; Veronique Nogueira; Nissim Hay; Angela L Tyner; Lester F Lau; Robert H Costa; Pradip Raychaudhuri
Journal:  EMBO J       Date:  2009-08-20       Impact factor: 11.598

5.  Down-regulation of Forkhead Box M1 transcription factor leads to the inhibition of invasion and angiogenesis of pancreatic cancer cells.

Authors:  Zhiwei Wang; Sanjeev Banerjee; Dejuan Kong; Yiwei Li; Fazlul H Sarkar
Journal:  Cancer Res       Date:  2007-09-01       Impact factor: 12.701

6.  Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche.

Authors:  Janine T Erler; Kevin L Bennewith; Thomas R Cox; Georgina Lang; Demelza Bird; Albert Koong; Quynh-Thu Le; Amato J Giaccia
Journal:  Cancer Cell       Date:  2009-01-06       Impact factor: 31.743

7.  p53 negatively regulates expression of FoxM1.

Authors:  Bulbul Pandit; Marianna Halasi; Andrei L Gartel
Journal:  Cell Cycle       Date:  2009-10-25       Impact factor: 4.534

8.  Pro-proliferative FoxM1 is a target of p53-mediated repression.

Authors:  A M Barsotti; C Prives
Journal:  Oncogene       Date:  2009-09-14       Impact factor: 9.867

9.  Plk1-dependent phosphorylation of FoxM1 regulates a transcriptional programme required for mitotic progression.

Authors:  Zheng Fu; Liviu Malureanu; Jun Huang; Wei Wang; Hao Li; Jan M van Deursen; Donald J Tindall; Junjie Chen
Journal:  Nat Cell Biol       Date:  2008-09       Impact factor: 28.824

10.  Tight correlation between expression of the Forkhead transcription factor FOXM1 and HER2 in human breast cancer.

Authors:  Nuran Bektas; Anette ten Haaf; Jürgen Veeck; Peter Johannes Wild; Juliane Lüscher-Firzlaff; Arndt Hartmann; Ruth Knüchel; Edgar Dahl
Journal:  BMC Cancer       Date:  2008-02-06       Impact factor: 4.430

View more
  150 in total

Review 1.  Targeting forkhead box M1 transcription factor in breast cancer.

Authors:  Ruth M O'Regan; Rita Nahta
Journal:  Biochem Pharmacol       Date:  2018-05-31       Impact factor: 5.858

2.  FOXM1c promotes pancreatic cancer epithelial-to-mesenchymal transition and metastasis via upregulation of expression of the urokinase plasminogen activator system.

Authors:  Chen Huang; Dacheng Xie; Jiujie Cui; Qi Li; Yong Gao; Keping Xie
Journal:  Clin Cancer Res       Date:  2014-01-22       Impact factor: 12.531

3.  Opposing Roles of the Forkhead Box Factors FoxM1 and FoxA2 in Liver Cancer.

Authors:  Vaibhav Chand; Akshay Pandey; Dragana Kopanja; Grace Guzman; Pradip Raychaudhuri
Journal:  Mol Cancer Res       Date:  2019-02-27       Impact factor: 5.852

4.  Mutant P53 induces MELK expression by release of wild-type P53-dependent suppression of FOXM1.

Authors:  Lakshmi Reddy Bollu; Jonathan Shepherd; Dekuang Zhao; Yanxia Ma; William Tahaney; Corey Speers; Abhijit Mazumdar; Gordon B Mills; Powel H Brown
Journal:  NPJ Breast Cancer       Date:  2020-01-03

Review 5.  FoxM1: a novel tumor biomarker of lung cancer.

Authors:  Jia Zhang; Jing Zhang; Xiaohai Cui; Ya Yang; Min Li; Jingkun Qu; Junhai Li; Jiansheng Wang
Journal:  Int J Clin Exp Med       Date:  2015-03-15

6.  A time-series analysis of altered histone H3 acetylation and gene expression during the course of MMAIII-induced malignant transformation of urinary bladder cells.

Authors:  Jinqiu Zhu; Jie Wang; Xushen Chen; Maria Tsompana; Daniel Gaile; Michael Buck; Xuefeng Ren
Journal:  Carcinogenesis       Date:  2017-04-01       Impact factor: 4.944

Review 7.  Functional O-GlcNAc modifications: implications in molecular regulation and pathophysiology.

Authors:  Krithika Vaidyanathan; Sean Durning; Lance Wells
Journal:  Crit Rev Biochem Mol Biol       Date:  2014-02-14       Impact factor: 8.250

8.  Overexpression of FOXM1 as a target for malignant progression of esophageal squamous cell carcinoma.

Authors:  Liang Song; Xiaohang Wang; Zhen Feng
Journal:  Oncol Lett       Date:  2018-02-13       Impact factor: 2.967

9.  Identification of master regulator genes of UV response and their implications for skin carcinogenesis.

Authors:  Yao Shen; Gabriel Chan; Michael Xie; Wangyong Zeng; Liang Liu
Journal:  Carcinogenesis       Date:  2019-07-04       Impact factor: 4.944

10.  Silencing of FOXM1 transcription factor expression by adenovirus-mediated RNA interference inhibits human hepatocellular carcinoma growth.

Authors:  T Chen; J Xiong; C Yang; L Shan; G Tan; L Yu; Y Tan
Journal:  Cancer Gene Ther       Date:  2014-02-28       Impact factor: 5.987

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.